Drugs / N,N-dimethyltryptamine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04716335 | Dec 2020 → Jul 2021 | CGF1 | Psychiatric University Hospital, Zurich | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N,N-dimethyltryptamine | “This traditional Amazonian plant decoction contains N,N-dimethyltryptamine (DMT) and β-carboline alkaloids such as harmine.” PMID 39774840 ↗ Dec 2024 |
| Known as | DMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04716335 ↗ |
| Route | Intranasal | “100 mg intranasal DMT” PMID 39774840 ↗ Dec 2024 |